Health Investment Partners

The firm invests across Western and Northern Europe. While headquartered in Amsterdam—a major hub for health-tech investment—its mandate covers companies facing the challenge of scaling across fragmented European healthcare markets, not exclusively Dutch ones.

Health Investment Partners provides growth equity and expansion capital. It focuses on companies that have already achieved clinical validation or regulatory approval and now require specialized capital and operational expertise to scale commercially, spanning both early-stage and late-stage growth rounds.

The firm concentrates on medical devices, digital health platforms, and healthcare services. These are sub-sectors where the path from regulatory approval to broad clinical adoption varies significantly by country, creating a role for an investor with deep domain-specific knowledge.

The firm is structured as a specialized private equity asset manager, not a family office. It raises external discretionary capital rather than managing a single family's wealth, and it operates with a dedicated healthcare sector mandate.

The firm does not publicly name its managing principals or investment committee members. Public records do not disclose the individuals responsible for final allocation decisions, a notable gap for institutional due diligence given the firm's specialized mandate.